PubMed Health⌕ Search

PubMed · 3382145

Shiley INFUSAID Pump technology.

Abstract

Totally implantable drug delivery devices have been shown to be safe and effective in the delivery of drugs both systemically and regionally. Applications have been developed for continuous infusions of drugs and are currently being developed for variable flow rates with more sophisticated programmable pumps. Some of the potential benefits of such devices include improved drug efficacy with reduced systemic toxicities, more controlled dosing of drugs, improved quality of life, delivery of proteins and peptides, and individualized patient dosing. The potential exists for creating biofeedback closed loop therapies for diabetes, cardiovascular diseases, and some central nervous system diseases in the future.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Johnston, S Reich, A Bailey, J Sluetz. 1988. Shiley INFUSAID Pump technology.. https://doi.org/10.1111/j.1749-6632.1988.tb31812.x. https://pubmed.health/record/pubmed%3A3382145/shiley-infusaid-pump-technology

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related citations

Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes.

Immune heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin. It can result from any type of heparin exposure and by any route of administration; however only a few cases are reported after exposures to small quantities of heparin from catheter flushes. The major clinical problem associated with HIT is thrombosis. Early detection and institution of alternative, non-heparin anticoagulation are important. We report a patient with HIT associated with use of therapeutic-dose unfractionated heparin in whom immune sensitization to heparin was triggered by two 500-unit exposure to UFH associated with intravascular catheter flushing for antineoplastic chemotherapy in a patient with colon adenocarcinoma.

Catheterization↗